Clinical Liver Disease

Immunosuppression: Conventions and Controversies - Neil Mehta and Ryutaro Hirose – Article Reading

Informações:

Sinopsis

Liver transplant recipients generally need lifelong immunosuppression - approximately 7 to 17 per cent of patients experience an episode of acute cellular rejection with 3 to 12 months of LT, respectively.